Showing results (21-30 of 61) with videos related to

Sort By:
Pageof 7
Immunology Letters|October 15, 2015
Myeloid-derived suppressor cells in human peripheral blood: Optimized quantification in healthy donors and patients with metastatic renal cell carcinomaAnne Flörcken, Anna Takvorian, Anju Singh, et al.
Annals of Hematology|May 22, 2015
Flow cytometric maturity score as a novel prognostic parameter in patients with acute myeloid leukemiaTanja Schneider, Anne Flörcken, Anju Singh, et al.
Leukemia & Lymphoma|May 31, 2018
AML: high serum ferritin at initial diagnosis has a negative impact on long-term survivalJana Ihlow, Sophia Gross, Annabel Sick, et al.
Cancers|September 12, 2018
miR-9-5p in Nephrectomy Specimens is a Potential Predictor of Primary Resistance to First-Line Treatment with Tyrosine Kinase Inhibitors in Patients with Metastatic Renal Cell CarcinomaBernhard Ralla, Jonas Busch, Anne Flörcken, et al.
The Journal of Gene Medicine|January 10, 2012
CCL19 (ELC) improves TH1-polarized immune responses and protective immunity in a murine Her2/neu DNA vaccination modelTam Nguyen-Hoai, Gerd Baldenhofer, Mona Sayed Ahmed, et al.
Palliative Care and Social Practice|July 24, 2024
Effective symptom relief through continuous integration of palliative care in advanced renal cell carcinoma patients: comprehensive measurement using the palliative care base assessmentAnne Dörr, Insa Vogel, Friedrich Wittenbecher, et al.
International Journal of Cancer|September 23, 2014
Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κBAnne Flörcken, Michael Grau, Annette Wolf, et al.
World Journal of Urology|April 23, 2011
Sequential mTOR inhibitor treatment with temsirolimus in metastatic renal cell carcinoma following failure of VEGF receptor tyrosine kinase inhibitorsSteffen Weikert, Carsten Kempkensteffen, Jonas Busch, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 7, 2018
CAR T Cells with Enhanced Sensitivity to B Cell Maturation Antigen for the Targeting of B Cell Non-Hodgkin's Lymphoma and Multiple MyelomaJulia Bluhm, Elisa Kieback, Stephen F Marino, et al.
Acta Haematologica|November 18, 2014
BCR-ABL1(+) acute myeloid leukemia: clonal selection of a BCR-ABL1(-) subclone as a cause of refractory disease with nilotinib treatmentNina Rosa Neuendorff, Michaela Schwarz, Philipp Hemmati, et al.
Pageof 7